abstract |
This invention relates to the novel proteins, termed LBDG1 and LBDG4, herein identified as Nuclear Hormone Receptor Ligand Binding Domains and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease. |